Doctor's Data competitors

Steve Rusckowski is Chairman, President and Chief Executive Officer of Quest Diagnostics. Since joining Quest Diagnostics as President and Chief Executive Officer in May 2012, Mr. Rusckowski has focused on transforming the company, based on its compelling vision of “Empowering better health with diagnostic insights.” Under his leadership, the company has refocused on its core diagnostic information services business, sold non-core assets, delivered disciplined deployment, including share repurchases and acquisitions, and simplified its organizational structure to better serve customers by removing complexity, speeding decision making and empowering employees. He was elected Chairman of the Board in December 2016. Prior to joining Quest Diagnostics, Mr. Rusckowski was CEO of Philips Healthcare, which became the largest unit of Royal Philips Electronics under his leadership. He joined Philips in 2001 when it acquired the Healthcare Solutions Group he was leading at Hewlett-Packard/Agilent Technologies. Mr. Rusckowski is a member of the Board of Directors of Project Hope, a global health education and humanitarian assistance organization. He is also a member of the Board of Directors of the American Clinical Laboratory Association, and served as its Chairman from 2014 to 2017. Mr. Rusckowski earned a Master of Science degree in Management from the Massachusetts Institute of Technology’s Sloan School of Management and a Bachelor of Science degree in Mechanical Engineering from Worcester Polytechnic Institute.

Christophe Berthoux is an Exec VP:Global Sales & Mktg/Chief Commercial Ofcr at CHARLES RIVER LABORATORIES, Member of the Board of Directors at Synexus, and Chairman at IMAGE ANALYSIS INC and is based in London, Greater London, United Kingdom. He has worked as CEO at Synexus, Chief Executive Officer at Synexus Clinical Research Ltd, and Gen Mgr:Clinical Svcs at CHARLES RIVER LABORATORIES.

Matt Bastardi has over 20 years of leadership experience in the medical device & diagnostics industry, having managed teams in corporate development, strategic planning, marketing, finance, and operations. Prior to Surgical Specialties, Matt was Senior Vice President, Corporate Development & Strategy for Accriva Diagnostics. Matt helped lead the transformation of Accriva Diagnostics resulting in the sale of the Company to Werfen. Earlier in his career, Matt was Vice President, Portfolio Management, Strategic Marketing & Business Development for Covidien. Matt also held roles in the OEM / contract manufacturing industry serving the medical device industry with FlexMedical and Accellent. He started his career in M&A investment banking for Alex. Brown & Sons. Matt earned an MBA from the Kellogg School of Management at Northwestern University, and a B.S. from Georgetown University.

Nicolas Cartier is a Chief Executive Officer at Merieux NutriSciences and is based in Lyon Area, France. He has worked as Assistant to the chairman and CEO at SANOFI; Executive VP, Industrial Microbiology at bioMérieux; and Sales Director, then Business Unit Director at SANOFI. Nicolas studied at Ecole nationale des Ponts et Chaussées between 1988 and 1991, Ecole Polytechnique between 1985 and 1988, and Sciences Po between 1988 and 1991.